Navigation Links
ApoBrdU Red DNA Fragmentation Kit from MBL International

ProductsApoBrdU Red DNA Fragmentation Kit from MBL International
Company MBL International
Item ApoBrdU Red DNA Fragmentation Kit
Price 
Description The TUNEL-based assay kit provides complete components including positive and negative control cells for convenient detection of DNA fragmentation in cultured cells and tissue sections. The incorporation of BrdU in the procedure provides greater sensitivity than biotinylated or digoxigenylated methods. Results can be analyzed by flow cytometry. The kit works well with GFP transfected cells

Internucleosomal DNA fragmentation is a hallmark of apoptosis in mammalian cells. MBLs Apo-BrdU In Situ DNA Fragmentation Assay Kit provides complete components including positive and negative control cells for conveniently detecting DNA fragmentation by fluorescence microscopy or flow cytometry. The kit utilizes Br-dUTP (bromolated deoxyuridine triphosphate nucleotides) which is more readily incorporated into DNA strand breaks than other larger ligands (e.g., fluorescein, biotin or digoxigenin). The greater incorporation gives rise to brighter signal when the Br-dUTP sites are identified by a red TRITC-labeled anti-BrdU monoclonal antibody. The assay is suitable for studying apoptosis in GFP- or Azami Green-transfected cells.
Info MBL InternationalMBL International
15 B Constitution Way
Woburn, MA 01801
Customer Service: 781-939-6964
Fax Number: 781-939-6963
Web Site: http://mblintl.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. ApoBrdU DNA Fragmentation Assay Kit from MBL International
2. ApoDIRECT DNA Fragmentation Assay Kit from MBL International
3. Osteoclasts Culture Kit from B-Bridge International
4. Rat siTrio from B-Bridge International
5. Human siTrio from B-Bridge International
6. Human siTrio from B-Bridge International
7. Rat siTrio from B-Bridge International
8. Rat siTrio from B-Bridge International
9. Rat siTrio Add-on from B-Bridge International
10. siSolutions RNAi Services from B-Bridge International
11. FAM FLISP™ Spacer-Leu-CMK Assay Kit from B-Bridge International
SAIVI Alexa Fluor 680 injectable contrast agent *bovine serum albumin*...
... contains the cellular components necessary for protein ... and termination factors) but has not been ... used primarily for the isolation of these ... endogenous globin mRNA. Untreated Lysate is prepared ...
RAT ANTI MOUSE METALLOPHILIC MACROPHAGES...
Coverslips for Microarrays, 1. *Category: MICROARRAY ACCESSORIES....
Biology Products:
(Date:3/2/2017)... March 2, 2017 Summary This report ... and its partnering interests and activities since 2010. ... Read the full ... Alliance since 2010 report provides an in-depth insight into the ... companies. On demand company reports are prepared upon ...
(Date:3/1/2017)... , March 1, 2017  Aware, Inc. (NASDAQ: ... announced that Richard P. Moberg has resigned, ... co-President and Chief Financial Officer and Treasurer of Aware ... to serve as a member of the Board of ... , Aware,s co-Chief Executive Officer and co-President, General Counsel ...
(Date:2/27/2017)... 2017   Strategic Cyber Ventures , the industry,s ... a $3.5 million investment in  Polarity , the first ... is DC based and is led by cybersecurity veterans ... Ron Gula , also a longtime cybersecurity veteran ... this series A round of funding. This new funding ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... MONICA, Calif. , March 22, 2017 /PRNewswire/ ... are proud to announce their extended partnership and ... will be headlined by the 21 st ... BIOMEDevice Boston, taking place May 3-4, 2017. ... Advanced Medical Technology Association (ADVAMED) President and CEO, ...
(Date:3/22/2017)... , March 22, 2017 Oramed ... ( www.oramed.com ), a ... oral drug delivery systems, announced today that Dr. ... will deliver a presentation titled, "Oral Insulin for ... Cambridge Healthtech Institute,s Oligonucleotide and Peptide Therapeutics (OPT) ...
(Date:3/22/2017)... , March 22, 2017 ... fragmented, states a research report by Transparency Market Research ... Inc., Amgen Inc., and AbbVie Inc., accounted for a ... The prominent players in this market are focusing aggressively ... product portfolio, which is likely to lead to market ...
(Date:3/22/2017)... - FACIT announced a seed stage investment in ... created by FACIT focused on developing a portfolio ... non-dilutive capital, achieves a targeted $3.0M financing for ... to accelerate the nomination of a candidate drug ... a strategic partnership for clinical trials in patients ...
Breaking Biology Technology: